scholarly article | Q13442814 |
P356 | DOI | 10.1097/00007435-199605000-00013 |
P698 | PubMed publication ID | 8724515 |
P2093 | author name string | Sapp M | |
Schiller J | |||
Dillner J | |||
Andersson-Ellström A | |||
Milsom I | |||
Forssman L | |||
Hagmar B | |||
P433 | issue | 3 | |
P921 | main subject | antibody | Q79460 |
P304 | page(s) | 234-238 | |
P577 | publication date | 1996-05-01 | |
P1433 | published in | Sexually Transmitted Diseases | Q15763556 |
P1476 | title | Comparison of development of serum antibodies to HPV16 and HPV33 and acquisition of cervical HPV DNA among sexually experienced and virginal young girls. A longitudinal cohort study. | |
P478 | volume | 23 |
Q36645918 | A prospective study of the relationship between prediagnostic human papillomavirus seropositivity and HPV DNA in subsequent cervical carcinomas |
Q71733553 | A prospective study on the risk of cervical intra-epithelial neoplasia among healthy subjects with serum antibodies to HPV compared with HPV DNA in cervical smears |
Q36609068 | Age-specific human papillomavirus antibody and deoxyribonucleic acid prevalence: a global review |
Q35566274 | Attack rates of human papillomavirus type 16 and cervical neoplasia in primiparous women and field trial designs for HPV16 vaccination |
Q36542076 | Cervical mucus antibodies against human papillomavirus type 16, 18, and 33 capsids in relation to presence of viral DNA |
Q36376205 | Genital human papillomavirus (HPV) concordance in heterosexual couples. |
Q50535432 | HPV 16 antibody prevalence in Jamaica and the United States reflects differences in cervical cancer rates. |
Q50537413 | Human papillomavirus infection and esophageal cancer: a nationwide seroepidemiologic case-control study in Sweden. |
Q33736749 | Human papillomavirus infection in adolescents |
Q34305225 | Immunity to oncogenic human papillomaviruses |
Q35562265 | Immunoglobulin A, G, and M responses to L1 and L2 capsids of human papillomavirus types 6, 11, 16, 18, and 33 L1 after newly acquired infection |
Q41103016 | Immunology of papillomavirus infection. |
Q40833121 | Intraepithelial carcinoma of the cervix: reflections on half a century of progress |
Q45722771 | Mapping of human serum-reactive epitopes in virus-like particles of human papillomavirus types 16 and 11. |
Q37137430 | New Approaches to Immunotherapy for HPV Associated Cancers |
Q50857924 | Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. |
Q37001336 | Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis |
Q33974260 | Prevalence of anti-human papillomavirus type 16, 18, 31, and 58 virus-like particles in women in the general population and in prostitutes |
Q73223002 | Prospects for phase III-IV HPV vaccination trials in the Nordic countries and in Estonia |
Q51871486 | Seroepidemiology as basis for design of a human papillomavirus vaccination program. |
Q45744835 | Seroepidemiology of human papillomavirus type 73: a sexually transmitted low-risk virus |
Q45733679 | Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in colombian women with invasive cervical cancer |
Q33936598 | Seropositivity against HPV 16 capsids: a better marker of past sexual behaviour than presence of HPV DNA |
Q34310582 | Seroprevalence of human papillomavirus types 6, 11, 16 and 18 in Chinese women |
Q36671130 | Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10 000 women in Costa Rica |
Q36539107 | Seroprevalences of herpes simplex virus type 2, five oncogenic human papillomaviruses, and Chlamydia trachomatis in Katowice, Poland |
Q37855949 | Smoking impairs human papillomavirus (HPV) type 16 and 18 capsids antibody response following natural HPV infection |
Q36641617 | Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection |
Q56959542 | Strategies for immunoprophylaxis and immunotherapy of papillomaviruses |
Q39727597 | The first international standard for antibodies to HPV 16. |
Q45103275 | Trends in seroprevalence of human papillomavirus type 16 among pregnant women in Stockholm, Sweden, during 1969-1989. |
Q34089060 | Trends over time in the incidence of cervical neoplasia in comparison to trends over time in human papillomavirus infection |
Search more.